blog

Glycanostics, Ltd. is one of the three winners of the ENRICH in the USA (European Network of Research and Innovation Centres and Hubs) funding summit –

We have been awarded the ISO 9001:2015 certificate in Research and Development of In-vitro Diagnostics Medical Devices.

You could meet us once again at the EIC Accelerator Awareness Event for Czech Republic and Slovakia, which took place in Brno, Czech Republic, on

Tests developed by the innovative Slovak company Glycanostics bring hope and solutions for the early non-invasive diagnosis of prostate cancer and 10 other types of

Our CEO Eva Kovacova presented Glycanostic’s success story as well as learnings and experience with the EIC Accelerator scheme during the EU Finance Day for

Our CEO Eva Kovacova was invited to present at the workshop organized by JRC’s Competence Centre on Technology Transfer that brought together key stakeholders of

Our CEO Eva Kovacova was invited by EU Commissioner Mariya Gabriel to a meeting in Sofia, to launch the first European Women founders group consisting

Our CSO Ján Tkáč was invited to give a presentation at the Regional seminar of pneumologists that brought together pneumologists from the Bratislava region. We

After a long break due to COVID pandemic, we attended an in-person Life Science Executive Leaders (LSX) conference on May 10th and 11th in London.

We are happy to announce that our team is growing. Warm welcome to our R&D, marketing, business development, HR and office admin team members! We

Glycanostics has become a member of the Oslo Cancer Cluster (OCC), an oncology research and industry cluster dedicated to improving the lives of cancer patients

Applications that meet all the criteria but are not recommended for funding due to budget limitations will be awarded a Seal of Excellence to help